1. Background {#sec148395}
=============

Superficial infections such as burn, wound and post-surgical site infections are important causes of emergency health care-associated problems all around the world. Superficial infections cause longer hospital stays, more expensive hospitalizations and increased mortality ([@A27646R1]). The annual superficial infection care products market is projected to reach \$15.3 billion by 2010 ([@A27646R1]). *Pseudomonas aeruginosa* are non-fermentative, aerobic, gram-negative rod shape bacteria, which substantially contribute to wound-related morbidity and mortality worldwide. They are widely distributed, mostly in hospital environments and are one of the most important agents of hospital-acquired superficial infections, ecthyma gangrenosum and black necrotic lesions ([@A27646R2], [@A27646R3]). Superficial infections caused by *P. aeruginosa* are one of the most prevalent causes of hospitalization and emergency health care references all around the world ([@A27646R2]-[@A27646R6]).

Treatment of superficial infections caused by *P. aeruginosa* often requires antibiotic therapy yet the levels of antibiotic resistance in the rough strains of these bacteria have increased over time ([@A27646R7]-[@A27646R11]). Therefore, it is essential to study the levels of antibiotic resistance in the *P. aeruginosa* isolates of each region and even each hospital.

In the recent years, the growing incidence of *P. aeruginosa* has been of particular concern. The incidence of *P. aeruginosa* in superficial and wound infections is becoming more serious in developing countries like Iran ([@A27646R12], [@A27646R13]). This issue is of higher importance for females and elders, due to their relatively lower levels of immune system.

2. Objectives {#sec148396}
=============

The present study was carried out in order to study the antibiotic resistance pattern of *P. aeruginosa* isolated from cases of superficial infections referred to the emergency health care units of Iranian Hospitals.

3. Materials and Methods {#sec148405}
========================

3.1. Ethical Considerations {#sec148397}
---------------------------

Ethical committees of the educational hospitals approved the general principles and framework of the present investigation. Written informed consent was obtained from all of the study patients or their parents. Personal information of all patients remained confidential.

3.2. Sample Collection {#sec148398}
----------------------

From June 2014 to October 2015, a total of 300 swab samples were taken from patients with superficial infections referred to the emergency health care units of Iranian hospitals. Swab samples were taken from various types of superficial infections including wound (n = 110), burn (n = 90) and post-surgical site (n = 100) infections. Personal information like age and gender were recorded for each sample and all samples were transferred to the laboratory in a cooler with an ice pack.

3.3. *Pseudomonas aeruginosa* Isolation {#sec148399}
---------------------------------------

Swab samples were inoculated on blood, MacConkey (Merck, Germany) and nutrient agar (Merck, Germany) and incubated at 37°C for 24 hours. Colonies that produced pyoverdin, pyocyanin and pyorubin pigments were transferred to nutrient agar and subcultured more than one time to obtain pure cultures. The isolates were identified using conventional biochemical tests such as motility, oxidase, catalase, citrate utilization, gelatinase liquefaction, urease production, nitrate reduction, alkaline protease production, triple sugar iron agar, oxidative-fermentative, indole, lecithinase production and hemolysin production.

3.4. Antimicrobial Susceptibility Testing of *P. aeruginosa* Isolates {#sec148400}
---------------------------------------------------------------------

Pattern of antimicrobial resistance was studied using the simple disk diffusion technique. The Mueller-Hinton agar (Merck, Germany) medium was used for this purpose. Antibiotic resistance of *P. aeruginosa* strains against 12 commonly used antibiotics, including norfloxacin (30 µg/disk), ampicillin (10 u/disk), imipenem (30 u/disk), gentamycin (10 µg/disk), ciprofloxacin (5 µg/disk), cefepime (30 µg/disk), cotrimoxazole (30 µg/disk), polymyxin B (300 U/disk), meropenem (10 µg/disk), amikacin (30 u/disk), ceftazidime (30 µg/disk) and aztreonam (30 µg/disk) antibiotic agents (Oxoid, UK) was analyzed using the Clinical Laboratory Standard Institute protocol (CLSI) ([@A27646R14]). *P. aeruginosa* ATCC 27853 was used as a quality control in each reaction.

3.5. DNA Extraction From the *P. aeruginosa* Isolates {#sec148401}
-----------------------------------------------------

Total genomic DNA was extracted from the bacterial colonies. A single colony was inoculated on 5 mL of brain heart infusion broth and incubated over night at 37ºC. Then 1.5 mL of a saturated culture was harvested with centrifugation for five minutes at 14,000 rpm. The cell pellet was resuspended and lysed in 200 µL of lysis buffer (40 mM Tris-acetate pH 7.8, 20 mM sodium-acetate, 1 mM EDTA, 1% SDS) by vigorous pipetting. To remove most proteins and cell debris, 66 µL of 5M NaCl solution was added and mixed well, and then the viscous mixture was centrifuged at 12,000 rpm for 10 minutes at 4ºC. After transferring the clear supernatant to a new eppendorf tube, an equal volume of chloroform was added, and the tube was gently inverted at least 50 times when a milky solution was completely formed. Following centrifugation at 14,000 rpm for five minutes, the supernatant was then removed to another eppendorf tube and double volume of 100% ethanol was added. The tubes were gently inverted five to six times, then centrifuged at 10000 rpm for five minutes. The supernatant was discarded and 1 mL of ethanol (70%) was added to the pellet, and tubes were centrifuged at 10000 rpm for five minutes. Finally, the supernatant was discarded and the pellet was dried for 10 minutes at room temperature and was then resuspended in 100 µL H~2~O. The stock was kept at -20ºC until use. The DNA concentration was determined by measuring absorbance of the sample at 260 nm, using a spectrophotometer ([@A27646R15]).

3.6. Polymerase Chain Reaction Amplification For Confirmation of *P. aeruginosa* {#sec148402}
--------------------------------------------------------------------------------

Genomic DNA extracted from the bacterial colonies was confirmed to be *P. aeruginosa* using the PCR technique. The PCR mixture contained 200 µM of each dNTP (Fermentas, Germany), PCR buffer (10 mM Tris/HCl, 50 mM KCl, 1.5 mM MgCl2, pH 8.3), DMSO at a final concentration of 4%, 12.5 pmol of each primer (F: 5'- GGGGGATCTTCGGACCTCA -3' and R: 5'- TCCTTAGAGTGCCCACCCG -3', 956 bp) ([@A27646R16]), 1 U Taq DNA polymerase (Fermentas, Germany) and 25 ng DNA template. The DNA was amplified in a programmable thermal cycler (Eppendorf, Mastercycler® 5330, Eppendorf-Netheler-Hinz GmbH, Hamburg, Germany) PCR device using the following protocol: 94ºC for one minute, 30 cycles of 94ºC for 35 seconds, 58ºC for 60 seconds, 72ºC for 60 seconds, and 72ºC for five minutes. *P. aeruginosa* ATCC 27853 were used as positive controls and distilled water (D. W, Merck, Germany) was used as a negative control in all PCR reactions.

3.7. Agarose Gel Electrophoresis {#sec148403}
--------------------------------

Fifteen microliters of PCR products were resolved on a 1.5% agarose gel containing 0.5 mg/mL of SYBR Green in trisborate EDTA buffer at 90 V for 40 minutes, also using suitable molecular weight markers. The products were examined under ultraviolet illumination.

3.8. Statistical Analysis {#sec148404}
-------------------------

The results were transferred to a microsoft excel spreadsheet (Microsoft Corp., Redmond, WA) for analysis. Statistical analysis was performed using the SPSS/16.0 software (SPSS Inc., Chicago, IL) for significant relationships between incidences of antibiotic resistance of *P. aeruginosa* isolated from the samples of superficial infections. The chi-square test and Fisher's exact 2-tailed test analysis were performed in this study. Statistical significance was regarded at a P \< 0.05.

4. Results {#sec148406}
==========

The present investigation was carried out to study the prevalence of antibiotic resistance of *P. aeruginosa* isolated from various types of superficial infections. [Table 1](#tbl37997){ref-type="table"} shows the total distribution of *P. aeruginosa* in the swab samples taken from various types of superficial infections. Of the 300 studied swabs, 172 (57.3) samples were found to be contaminated with *P. aeruginosa*. The results of the culture technique were also confirmed using the PCR method ([Figure 1](#fig28077){ref-type="fig"}). Swab samples, which were taken from female cases (64.2%), patients older than 70 years (68.5%) and cases of burn infections (66.6%), had the highest prevalence of *P. aeruginosa*. Statistically significant differences were seen in the prevalence of *P. aeruginosa* between male and female cases (P = 0.039), younger than 10-years-old and older than 70-years-old patients (P = 0.016) and cases of burn infections and wound infections (P = 0.041).

###### Total Distribution of *P. aeruginosa* in the Swab Samples Taken From Various Types of Superficial Infections

  Different Criteria      No Samples   *P. aeruginosa* ^[a](#fn40875){ref-type="table-fn"}^
  ----------------------- ------------ ------------------------------------------------------
  **Gender**                           
  Male                    160          82 (51.2)
  Female                  140          90 (64.2)
  **Age, y**                           
  \< 10                   40           25 (62.5)
  10-30                   60           28 (46.6)
  30-50                   60           31 (51.6)
  50-70                   70           40 (57.1)
  \> 70                   70           48 (68.5)
  **Type of infection**                
  Wound                   110          50 (45.4)
  Burn                    90           60 (66.6)
  Post-surgical site      100          62 (62)
  **Total**               300          172 (57.3)

^a^Values are expressed as No. (%).

![Gel Electrophoresis for the Amplification of *P. aeruginosa* in the Swab Samples Taken From Superficial Infections\
M, 100 bp ladder; 1, Positive samples (956 bp); 2, Positive control (*P. aeruginosa* ATCC 27853); 3, Negative control (distilled water (D.W, Merck, Germany)).](jjm-09-01-27646-g001){#fig28077}

[Table 2](#tbl37998){ref-type="table"} shows the antibiotic resistance pattern of *P. aeruginosa* isolated from various types of superficial infections. We found that the *P. aeruginosa* strains of superficial infections harbored the highest levels of resistance against ampicillin (93%), gentamycin (89.5%), ciprofloxacin (82.5%) and amikacin (77.3%), and also the lowest levels of resistance against meropenem (2.3%), imipenem (2.9%), polymyxin B (21.5%) and cotrimoxazole (31.9%). *P. aeruginosa* strains of males had a higher prevalence of antibiotic resistance than females (P = 0.026). Statistically significant differences were seen between the type of infection and prevalence of antibiotic resistance (P = 0.044), and also between the age of patients and prevalence of antibiotic resistance (P = 0.032).

###### Antibiotic Resistance Pattern of *P. aeruginosa* Isolated From Patients Referred to the Emergency Units of Several Iranian Hospitals

  Different Criteria      Number of Positive   Antibiotic Resistance Pattern ^[a](#fn40876){ref-type="table-fn"}^                                                                                                                           
  ----------------------- -------------------- -------------------------------------------------------------------- ----------- ---------- ------------ ------------ ----------- ----------- ----------- --------- ------------ ----------- -----------
  **Gender**                                                                                                                                                                                                                                
  Male                    82                   35 (42.6)                                                            81 (98.7)   4 (4.8)    78 (95.1)    75 (91.4)    38 (46.3)   31 (37.8)   22 (26.8)   3 (3.6)   70 (85.3)    35 (42.6)   36 (43.9)
  Female                  90                   29 (32.2)                                                            79 (87.7)   1 (1.1)    76 (84.4)    67 (74.4)    30 (33.3)   26 (28.8)   15 (16.6)   1 (1.1)   63 (70)      25 (27.7)   22 (24.4)
  **Age, y**                                                                                                                                                                                                                                
  \< 10                   25                   4 (16)                                                               18 (72)     NA         16 (64)      13 (52)      4 (16)      4 (16)      2 (8)       NA        13 (52)      4 (16)      4 (16)
  10-30                   28                   9 (32.1)                                                             25 (89.2)   NA         24 (85.7)    22 (78.5)    10 (35.7)   7 (25)      4 (14.2)    NA        18 (64.2)    8 (28.5)    8 (28.5)
  30-50                   31                   12 (38.7)                                                            29 (93.5)   1 (3.2)    28 (90.3)    25 (80.6)    13 (41.9)   10 (32.2)   7 (22.5)    NA        27 (87)      11 (35.4)   10 (32.2)
  50-70                   40                   17 (42.5)                                                            40 (100)    1 (2.5)    39 (97.5)    37 (92.5)    18 (45)     13 (32.5)   10 (25)     1 (2.5)   34 (85)      14 (35)     13 (32.5)
  \> 70                   48                   22 (45.8)                                                            48 (100)    3 (6.25)   47 (97.9)    45 (93.7)    23 (47.9)   21 (43.7)   14 (29.1)   3 (6.2)   41 (85.4)    23 (47.9)   23 (47.9)
  **Type of infection**                                                                                                                                                                                                                     
  Wound                   50                   18 (36)                                                              42 (84)     1 (2)      40 (80)      34 (68)      17 (34)     14 (28)     12 (24)     NA        30 (60)      15 (30)     15 (30)
  Burn                    60                   25 (41.6)                                                            60 (100)    3 (5)      60 (100)     60 (100)     30 (50)     24 (40)     15 (25)     3 (5)     58 (96.6)    26 (43.3)   25 (41.6)
  Post-surgical site      62                   21 (33.8)                                                            58 (93.5)   1 (1.6)    54 (87)      48 (77.4)    21 (33.8)   17 (27.4)   10 (16.1)   1 (1.6)   45 (72.5)    19 (30.6)   18 (29)
  **Total**               172                  64 (37.2)                                                            160 (93)    5 (2.9)    154 (89.5)   142 (82.5)   68 (39.5)   55 (31.9)   37 (21.5)   4 (2.3)   133 (77.3)   60 (34.8)   58 (33.7)

^a^Values are expressed as No. (%).

5. Discussion {#sec148407}
=============

The results of the present study showed that *P. aeruginosa* has a higher prevalence in various types of superficial infections. Overall, 62.6% of the swab samples were positive for *P. aeruginosa*. To the best of our knowledge, this finding is the highest prevalence of *P. aeruginosa* in swab samples of superficial infections. Lower prevalence rate of *P. aeruginosa* in human superficial infections have been reported previously by Ranjan et al. (2010) (27.7%) ([@A27646R2]), Bhattacharjee et al. (2006) (32%) ([@A27646R4]), Oguntibeju and Nwobu (2004) (33.2%) ([@A27646R5]), Masaadeh and Jaran (2009) (27.78%) ([@A27646R6]) and Siguan et al. (1990) (18.8%) ([@A27646R17]).

High prevalence of *P. aeruginosa* in the clinical samples of our study maybe due to the fact that the type of samples (swabs samples of the site of infection) and health care managements is different with those of other investigations. In fact, the presence of environmental pollution, especially in the hospital environment as well as contaminated and lack of optimal disinfection of instruments and equipment of hospitals are the main reasons for the high prevalence of *P. aeruginosa* (62%) in post-surgical site infections of our study. Low levels of healthcare management in Iranian healthcare units and hospitals have been recognized from the results of our study and the results of various previous Iranian investigations ([@A27646R13], [@A27646R18], [@A27646R19]). Higher sensitivities of female skin are a reason for the higher prevalence of *P. aeruginosa* in their superficial infections. Similar results were reported by Okon et al. (2009) ([@A27646R20]) and Mulu et al. (2012) ([@A27646R21]). Al-Hasan et al. (2008) ([@A27646R22]) and Khan et al. (2008) ([@A27646R7]) reported a higher prevalence of *P. aeruginosa* clinical infections in males than females, which were different to our results. Their reason for the high prevalence of bacteria in males is that they are more in contact with the polluted outside home environment. Also they do exhausting and hard work outside the home. Therefore, they are more prone to get superficial infections.

Aging, decrease in the levels of keratin skin cells and reduction in the level of immunity are reasonable factors for the higher prevalence of *P. aeruginosa* in older than 70-years-old patients. High prevalence of *P. aeruginosa* in old patients has been reported previously ([@A27646R23]-[@A27646R25]). In despite of the results of a previous investigation, which showed a high prevalence of *P. aeruginosa* in children ([@A27646R26]), the results of our study showed that less than ten years old patients had a lower prevalence of bacteria. One possible explanation for this finding is that the age range of younger than ten-year-old patients of our study was eight to ten years. On the other hand, there were no younger than eight-year-old pediatrics in our study population.

Our study also focused on the prevalence of antibiotic resistance in *P. aeruginosa* strains of superficial infections. We found that *P. aeruginosa* isolates had the highest levels of resistance against ampicillin (93%), gentamycin (89.5%), ciprofloxacin (82.5%) and amikacin (77.3%). In a study conducted in Nepal ([@A27646R27]), there was no resistance against ampicillin, gentamicin, norfloxacin and ofloxacin. The prevalence of resistance against ceftriaxone, cephalexin, ciprofloxacin and cotrimoxazole were 50%, 100%, 50% and 100%, respectively. An Indian investigation revealed that the *P. aeruginosa* isolates of wound swab samples harbored the highest levels of resistance against tobramycin (66.3%), ciprofloxacin (87.93%), ceftazidime (73.27%), cefixime (84.48%), gentamycin (78.44%), amikacin (21.55%) and ofloxacin (87.93%), which was Similar to our findings. In a study, which was conducted in Ethiopia ([@A27646R28]), 40% of *P. aeruginosa* isolates were resistant to seven antibiotics including amoxicillin, ampicillin, ciprofloxacin, norfloxacin and gentamicin. In the cases of burn infections ([@A27646R29]), 70% of *P. aeruginosa* isolates were positive for metallo-beta-lactamase, with high prevalence of antibiotic resistance against ceftazidime (70%), chloramphenicol (68%) and gentamicin (62.5%). A recent Iranian investigation ([@A27646R30]) revealed that the *P. aeruginosa* strains isolated from the site of burn infections were resistant to cloxacillin (91.8%), cotrimoxazole (86%), cefazolin (83.7%), carbenicillin (74.4%), piperacillin (69.9%), ceftazidime (68.8%), ciprofloxacin (66.3%), tobramycin (58.2%), amikacin (48.8%) and gentamicin (37.2%), while the most effective antibiotic was imipenem with a resistance rate of 23.3%, which was similar to our results.

Irregular and unethical antibiotic prescription and even self-treatment by strong antibiotics cause such high levels of resistance in the *P. aeruginosa* strains of our investigation. Differences in the idea of medical practitioners in antibiotic prescription cause variations in the levels of antibiotic resistance against different antibiotics. In addition, the differences in the bactericidal activities of antibiotics and also difference in difficulty in developing resistance against various antibiotics are two other reasons for differences in the levels of antibiotic resistance.

The present study was one of the most extensive prevalence reports of *P. aeruginosa* and its antibiotic resistance pattern in the burn, post-surgical site and wound infection samples of emergency health care units of Iranian Hospitals. Our results showed that resistant strains of *P. aeruginosa* had a high prevalence in patients older than 70-years-old and especially in the samples taken from the site of burn infections. In keeping with this, the prevalence of these bacteria in cases of wound and post-surgical infections and also other studied groups were considerable. Hence, judicious use of antibiotics is required by clinicians. Also, because of the variation of resistance pattern in each hospital, it is important for each region and even hospital to formulate their own antibiotic policy, according to their local resistance pattern. We recommend the initial prescription of meropenem, imipenem and polymyxin B antibiotics for treatment of the cases of superficial infections in Iran.
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